Company logo

SAVA - Cassava Sciences, Inc.

NASDAQ -> Healthcare -> Biotechnology
Austin, United States

SAVA price evolution
SAVA
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $241.52 $278.25 $282.19 $93.51
Short term investments
Net receivables
Inventory
Total current assets $251.91 $279.56 $283.77 $93.99
Long term investments
Property, plant & equipment $20.93 $0.33 $0.28 $0.31
Goodwill & intangible assets $1.21
Total noncurrent assets $22.33 $1.75 $0.28 $0.31
Total investments
Total assets $274.25 $281.31 $284.05 $94.3
Current liabilities
Accounts payable $2.35 $1.91 $0.86 $0.91
Deferred revenue
Short long term debt $0.1 $0.09 $0.08 $0.06
Total current liabilities $6.33 $4.64 $2.65 $1.86
Long term debt $0.16 $0.19 $0.21 $0.23
Total noncurrent liabilities $0.36 $0.19 $0.21 $0.23
Total debt $0.26 $0.28 $0.3 $0.29
Total liabilities $6.68 $4.83 $2.86 $2.1
Shareholders' equity
Retained earnings -$193.13 -$183.57 -$178.45 -$174.92
Other shareholder equity
Total shareholder equity $267.56 $276.48 $281.19 $92.2
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $93.51 $23.08 $19.81 $10.48
Short term investments
Net receivables
Inventory
Total current assets $93.99 $23.35 $20.04 $10.66
Long term investments
Property, plant & equipment $0.31 $0.14 $0.09 $0.16
Goodwill & intangible assets
Total noncurrent assets $0.31 $0.14 $0.1 $0.17
Total investments
Total assets $94.3 $23.49 $20.14 $10.83
Current liabilities
Accounts payable $0.91 $0.45 $0.29 $0.42
Deferred revenue
Short long term debt $0.06 $0.09
Total current liabilities $1.86 $1.39 $0.51 $1.13
Long term debt $0.23
Total noncurrent liabilities $0.23
Total debt $0.29 $0.09
Total liabilities $2.1 $1.39 $0.51 $1.13
Shareholders' equity
Retained earnings -$174.92 -$168.59 -$163.96 -$157.4
Other shareholder equity
Total shareholder equity $92.2 $22.1 $19.63 $9.7
(in millions $) 30 Oct 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $3.9 $2.53 $1.52
Selling, general & administrative $1.24 $1 $1.1
Total operating expenses $5.14 $3.53 $2.62
Operating income -$5.14 -$3.53 -$2.62
Income from continuing operations
EBIT -$5.13 -$3.53 -$2.62
Income tax expense
Interest expense
Net income
Net income -$5.13 -$3.53 -$2.62
Income (for common shares) -$5.13 -$3.53 -$2.62
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $3.05 $1.57 $2.97 $7.62
Selling, general & administrative $3.74 $3.39 $3.69 $4.33
Total operating expenses $6.45 $4.96 $6.66 $11.95
Operating income -$6.45 -$4.96 -$6.66 -$11.95
Income from continuing operations
EBIT -$6.33 -$4.63 -$6.56 -$11.91
Income tax expense
Interest expense
Net income
Net income -$6.33 -$4.63 -$6.56 -$11.91
Income (for common shares) -$6.33 -$4.63 -$6.56 -$11.91
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income -$9.56 -$5.13 -$3.53 -$2.62
Operating activities
Depreciation $0.21 $0.01 $0 $0
Business acquisitions & disposals
Stock-based compensation $0.57 $0.41 $0.25 $0.24
Total cash flows from operations -$14.76 -$5.14 -$2.31 -$1.18
Investing activities
Capital expenditures -$22.04 -$0.07
Investments
Total cash flows from investing -$22.04 -$0.07 $0.36
Financing activities
Dividends paid
Sale and purchase of stock $0.07 $1.27 $190.99 $70.61
Net borrowings
Total cash flows from financing $0.07 $1.27 $190.99 $70.61
Effect of exchange rate
Change in cash and equivalents -$36.73 -$3.94 $188.69 $69.43
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income -$6.33 -$4.63 -$6.56 -$11.91
Operating activities
Depreciation $0.02 $0.06 $0.07 $0.07
Business acquisitions & disposals
Stock-based compensation $0.99 $1.3 $2.39 $2.97
Total cash flows from operations -$5.38 -$2.51 -$4.77 -$8.24
Investing activities
Capital expenditures $0.36 -$0.02
Investments $2.1
Total cash flows from investing $0.36 -$0.02 $2.1
Financing activities
Dividends paid
Sale and purchase of stock $75.45 $5.87 $14.1
Net borrowings
Total cash flows from financing $75.45 $5.81 $14.1
Effect of exchange rate
Change in cash and equivalents $70.42 $3.27 $9.33 -$6.14
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.02
Net debt/EBITDA N/A
Current ratio 39.82
Quick ratio 39.82